{"id":6101,"date":"2022-12-07T07:30:00","date_gmt":"2022-12-07T07:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/"},"modified":"2022-12-07T07:30:00","modified_gmt":"2022-12-07T07:30:00","slug":"rattelse-delarsrapport-220701-220930","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/rattelse-delarsrapport-220701-220930\/","title":{"rendered":"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Pressmeddelande 2022-12-07<\/strong><\/div>\n<p><span><span><span>F\u00f6retaget har i november 2022 uppt\u00e4ckt en felaktig redovisning av bidrag i Q3-rapporten i och med att erh\u00e5llna offentliga st\u00f6d redovisas som \u00f6vrig r\u00f6relseint\u00e4kt. Villkoren f\u00f6r de offentliga st\u00f6den inneb\u00e4r att st\u00f6den ska finansiera f\u00f6retagets utvecklingsprojekt och redovisas som f\u00f6rskott offentliga st\u00f6d p\u00e5 balansr\u00e4kningen.\u00a0<br \/>\nR\u00e4ttningen p\u00e5verkar inte f\u00f6retagets kassafl\u00f6de utan \u00e4r en flytt fr\u00e5n resultatr\u00e4kning till balansr\u00e4kning.<\/span><\/span><\/span><\/p>\n<p><span><span><span>P\u00e5verkan p\u00e5 moderbolaget och koncernen f\u00f6r Q3, 2022 blir enligt f\u00f6ljande:<\/span><\/span><\/span><\/p>\n<p><span><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"651\" src=\"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png\" width=\"1051\"\/><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><\/span><\/p>\n<p><span>Ina Laura Perkins, VD <\/span><\/p>\n<p><span>Tel: +46(0)70 406 49 21<\/span><\/p>\n<p><span>E-post: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"nofollow\">inalaura.perkins@realheart.se<\/a><\/span><\/p>\n<p><span>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, Telefon: +46 11 32 30\u00a0732, email:\u00a0<a href=\"mailto:ca@skmg.se\" rel=\"nofollow\">ca@skmg.se<\/a><\/span><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><em>Scandinavian Real Heart AB utvecklar ett komplett artificiellt hj\u00e4rta (Total Artificial Heart \u2013 TAH) f\u00f6r implantation i patienter med livshotande hj\u00e4rtsvikt. Bolagets TAH har en patenterad design som innefattar en kopiering av det naturliga m\u00e4nskliga hj\u00e4rtat. Realheart<\/em><\/span><em><span><span><span>\u00ae<\/span><\/span><\/span><\/em><span><em> TAH\u00a0inf\u00f6rlivar ett fyrkammarsystem (tv\u00e5 f\u00f6rmak, tv\u00e5 kamrar) vilket ger m\u00f6jlighet att generera ett fysiologiskt anpassat blodfl\u00f6de som efterliknar kroppens naturliga cirkulation. Ett koncept som \u00e4r unikt i den medicintekniska v\u00e4rlden. <\/em><\/span><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/rattelse-delarsrapport-220701-220930.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3676699%2F1718935.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/rattelse-delarsrapport-220701-220930.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3676699%2F1718935.pdf&type=jpg\"><\/span>R\u00e4ttelse: Del\u00e5rsrapport 220701-220930<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/realheart-delarsrapport-q3-2022-sv-221207.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3676699%2F9c7869ec8f6e3ec4.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/realheart-delarsrapport-q3-2022-sv-221207.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3676699%2F9c7869ec8f6e3ec4.pdf&type=jpg\"><\/span>Realheart Del\u00e5rsrapport Q3 2022 SV 221207<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande 2022-12-07 F\u00f6retaget har i november 2022 uppt\u00e4ckt en felaktig redovisning av bidrag i Q3-rapporten i och med att erh\u00e5llna offentliga st\u00f6d redovisas som \u00f6vrig r\u00f6relseint\u00e4kt. Villkoren f\u00f6r de offentliga st\u00f6den inneb\u00e4r att st\u00f6den ska finansiera f\u00f6retagets utvecklingsprojekt och redovisas som f\u00f6rskott offentliga st\u00f6d p\u00e5 balansr\u00e4kningen.\u00a0 R\u00e4ttningen p\u00e5verkar inte f\u00f6retagets kassafl\u00f6de utan \u00e4r en flytt&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6101","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande 2022-12-07 F\u00f6retaget har i november 2022 uppt\u00e4ckt en felaktig redovisning av bidrag i Q3-rapporten i och med att erh\u00e5llna offentliga st\u00f6d redovisas som \u00f6vrig r\u00f6relseint\u00e4kt. Villkoren f\u00f6r de offentliga st\u00f6den inneb\u00e4r att st\u00f6den ska finansiera f\u00f6retagets utvecklingsprojekt och redovisas som f\u00f6rskott offentliga st\u00f6d p\u00e5 balansr\u00e4kningen.\u00a0 R\u00e4ttningen p\u00e5verkar inte f\u00f6retagets kassafl\u00f6de utan \u00e4r en flytt...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/\",\"name\":\"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mb.cision.com\\\/Public\\\/12118\\\/3676699\\\/a265030480c807f5_800x800ar.png\",\"datePublished\":\"2022-12-07T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mb.cision.com\\\/Public\\\/12118\\\/3676699\\\/a265030480c807f5_800x800ar.png\",\"contentUrl\":\"https:\\\/\\\/mb.cision.com\\\/Public\\\/12118\\\/3676699\\\/a265030480c807f5_800x800ar.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/rattelse-delarsrapport-220701-220930\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/","og_locale":"sv_SE","og_type":"article","og_title":"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart","og_description":"Pressmeddelande 2022-12-07 F\u00f6retaget har i november 2022 uppt\u00e4ckt en felaktig redovisning av bidrag i Q3-rapporten i och med att erh\u00e5llna offentliga st\u00f6d redovisas som \u00f6vrig r\u00f6relseint\u00e4kt. Villkoren f\u00f6r de offentliga st\u00f6den inneb\u00e4r att st\u00f6den ska finansiera f\u00f6retagets utvecklingsprojekt och redovisas som f\u00f6rskott offentliga st\u00f6d p\u00e5 balansr\u00e4kningen.\u00a0 R\u00e4ttningen p\u00e5verkar inte f\u00f6retagets kassafl\u00f6de utan \u00e4r en flytt...","og_url":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/","og_site_name":"Realheart","og_image":[{"url":"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/","url":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/","name":"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/#primaryimage"},"image":{"@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/#primaryimage"},"thumbnailUrl":"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png","datePublished":"2022-12-07T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/#primaryimage","url":"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png","contentUrl":"https:\/\/mb.cision.com\/Public\/12118\/3676699\/a265030480c807f5_800x800ar.png"},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/rattelse-delarsrapport-220701-220930\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"R\u00e4ttelse: Del\u00e5rsrapport 220701-220930"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}